secwatch.observer — SEC 8-K summary
======================================

Issuer:     CytomX Therapeutics, Inc. (CTMX)
CIK:        0001501989
Form:       8-K
Filed at:   2025-05-28T23:59:59+00:00
Accession:  0001193125-25-129470
Event type: regulatory
Sentiment:  positive
Materiality: 0.55
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

CytomX regains Nasdaq minimum bid price compliance as of May 23, 2025
---------------------------------------------------------------------

- Nasdaq Staff notified company on May 27, 2025, of compliance regained.
- Closing price ≥ $1.00 for 10 consecutive trading days ended May 23, 2025.
- Resolves previous deficiency notice from February 24, 2025.
- Matter is now closed with no further action required.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1501989/000119312525129470/0001193125-25-129470-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1501989/000119312525129470/d932298d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-129470

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer